Perioperative antimicrobial prophylaxis in clean-contaminated head and neck squamous cell cancer surgeries: Is less better?

被引:1
|
作者
Kohli, Pavneet [1 ]
Penumadu, Prasanth [1 ]
Shukkur, Naveeth [1 ]
Sivasanker, M. [3 ]
Balasubramanian, Arumugam [1 ]
Ganapathy, Sachit [2 ]
机构
[1] JIPMER, Dept Surg Oncol, Pondicherry, India
[2] JIPMER, Dept Biostat, Pondicherry, India
[3] Royal Liverpool Univ Hosp NHS Trust, Dept Surg, Liverpool, Merseyside, England
关键词
Antibiotic misuse; antibiotic resistance; clean-contaminated surgery; head and neck surgery; oral cancer; SSI; SURGICAL SITE INFECTIONS; ANTIBIOTIC-PROPHYLAXIS; ONCOLOGIC SURGERY; SHORT-TERM; COMPLICATIONS; PREVENTION; CLASSIFICATION; METRONIDAZOLE; CLINDAMYCIN; CEFAZOLIN;
D O I
10.4103/jcrt.JCRT_1654_20
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Judicious use of antibiotics and stringent adherence to practice guidelines is the need of the hour as antibiotic resistance is a rampant problem. Despite several reports in the literature describing the optimal duration of antibiotics, there is no consensus. A "one for all" protocol may be impractical and hence the guidelines need to be tweaked to take into consideration local factors. We designed a protocol for prophylactic antibiotics in clean-contaminated head and neck cancer squamous cell carcinoma (HNSCC) surgeries to prevent unchecked abuse and evaluated its feasibility. Materials and Methods: Two hundred consecutive patients who underwent a clean-contaminated surgery for HNSCC between January 2017 and December 2019 were included. Single-dose intravenous amoxicillin-clavulanate at induction followed by three doses of amoxicillin-clavulanate, metronidazole, and amikacin in the postoperative period was used. Adherence to the antibiotic protocol was assessed from a prospectively maintained database. Results: The mean age was 55.99 +/- 11.71 years. The protocol was effective in 70% of the patients with an acceptable surgical site infection (SSI) rate of 12%. Flap-related complications (9.5%) and oro-cutaneous fistula (5%) were common causes of prolonged antibiotics. On univariate analysis, blood transfusion (P =.014), clinical stage at presentation (P =.028), patients undergoing reconstruction (P =.001), longer operative time (P =.009), and pathological T stage (P = 0.03) were at higher chance of deviating from the protocol. On multivariate analysis, age more than 50 years (OR: 2.14, 95% CI: (1.01, 4.52); P value = 0.047) and reconstruction (OR: 3.36, 95% CI: (1.21, 9.32); P value = 0.020) were found to be significant. Conclusions: A three-dose perioperative antibiotic prophylaxis in clean-contaminated HNSCC surgeries is feasible. Similar protocols should be developed and validated at other major centers to limit the unnecessary use of antibiotics and prevent the emergence of antibiotic resistance.
引用
收藏
页码:S170 / S176
页数:7
相关论文
共 50 条
  • [31] SCC-NET: segmentation of clinical cancer image for head and neck squamous cell carcinoma
    Huang, Chien-Yu
    Tsai, Cheng-Che
    Hwang, Lisa Alice
    Kang, Bor-Hwang
    Lin, Yaoh-Shiang
    Su, Hsing-Hao
    Shen, Guan-Ting
    Hsieh, Jun-Wei
    JOURNAL OF MEDICAL IMAGING, 2024, 11 (06)
  • [32] Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges
    Hu, Chen
    Zhang, Yifan
    Wu, Chunping
    Huang, Qiang
    CELL DEATH DISCOVERY, 2023, 9 (01)
  • [33] Identifying perioperative volume-related risk factors in head and neck surgeries with free flap reconstructions - An investigation with focus on the influence of red blood cell concentrates and noradrenaline use
    Grill, Florian D.
    Wasmaier, Maria
    Muecke, Thomas
    Ritschl, Lucas M.
    Wolff, Klaus-Dietrich
    Schneider, Gerhard
    Loeffelbein, Denys J.
    Kadera, Vojta
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2020, 48 (01) : 67 - 74
  • [34] Sarcopenia as a predictive factor for febrile neutropenia during induction chemotherapy in head and neck squamous cell cancer
    Kasahara, Ken
    Shigetomi, Seiji
    Sato, Yoichiro
    Imanishi, Yorihisa
    Ikari, Yuichi
    Nishiyama, Takanori
    Matsui, Yuki
    Shinden, Seiichi
    Ozawa, Hiroyuki
    Kono, Takeyuki
    AURIS NASUS LARYNX, 2024, 51 (06) : 971 - 975
  • [35] Human papillomavirus in squamous cell cancer of the head and neck. A study at the Ulm Military Hospital, Germany
    Maier, M.
    Kraft, K.
    Steinestel, K.
    Schramm, A.
    Lorenz, K. J.
    Tisch, M.
    Schwerer, M.
    Maier, H.
    HNO, 2013, 61 (07) : 593 - 601
  • [36] The cancer pain related factors affected by celecoxib together with cetuximab in head and neck squamous cell carcinoma
    Yang, Yaqiong
    Yan, Jia
    Huang, Yan
    Xu, Hui
    Zhang, Ying
    Hu, Rong
    Jiang, Jue
    Chen, Zhifeng
    Jiang, Hong
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 181 - 189
  • [37] High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma
    Salzman, Richard
    Pacal, Lukas
    Kankova, Katerina
    Tomandl, Josef
    Horakova, Zuzana
    Tothova, Eva
    Kostrica, Rom
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (06) : 565 - 570
  • [38] Clinical utility and prospective comparison of ultrasonography and computed tomography imaging in staging of neck metastases in head and neck squamous cell cancer in an Indian setup
    Ashraf, Mohammad
    Biswas, Jaydip
    Jha, Jayesh
    Nayak, Sandeep
    Singh, Vikas
    Majumdar, Suparna
    Bhowmick, Anup
    Dam, Aniruddha
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (06) : 686 - 693
  • [39] Incidence, timing, presentation, treatment, and outcomes of second primary head and neck squamous cell carcinoma after oral cancer
    Rogers, S. N.
    Swain, A.
    Carroll, C.
    Lowe, D.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2019, 57 (10) : 1074 - 1080
  • [40] The association of treatment delay and prognosis in head and neck squamous cell carcinoma (HNSCC) patients in a Dutch comprehensive cancer center
    van Harten, Michel C.
    de Ridder, Mischa
    Hamming-Vrieze, Olga
    Smeele, Ludi E.
    Balm, Alfons J. M.
    van den Brekel, Michiel W. M.
    ORAL ONCOLOGY, 2014, 50 (04) : 282 - 290